68Ga-DOTATATE PET/CT in Focal Fatty Sparing of the Liver

Nir Hod, Daniel Levin, Reut Anconina, Benjamin H. Taragin, Julia Dudnik, Sophie Lantsberg

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


68Ga-DOTATATE imaging is commonly used for the detection of metastatic disease in neuroendocrine tumors. We present a case of a 69-year-old woman postsurgery for lung carcinoid tumor in which sequential follow-up 68Ga-DOTATATE PET/CT studies identified focal hepatic uptake that was presumed to represent a liver metastasis. However, correlative imaging with MRI revealed a focal fatty sparing of the liver composed of benign hepatic parenchyma at that area accompanied with diffuse liver steatosis in the background of the "pseudolesion." This report demonstrates a potential "false-positive" hepatic finding that can strikingly mimic a metastasis in neuroendocrine tumor imaging.

Original languageEnglish
Pages (from-to)815-817
Number of pages3
JournalClinical Nuclear Medicine
Issue number10
StatePublished - 1 Oct 2019
Externally publishedYes


  • "false-positive"
  • MRI
  • PET/CT
  • fatty liver
  • focal fatty sparing
  • neuroendocrine tumor imaging


Dive into the research topics of '<sup>68</sup>Ga-DOTATATE PET/CT in Focal Fatty Sparing of the Liver'. Together they form a unique fingerprint.

Cite this